Transatlantic Business Dialogue
Executive Summary
Five CEOs from U.S. generic pharmaceutical companies are invited to participate in TABD's CEO conference in Berlin Oct. 29-30. The group, which convenes working groups to allow U.S. and EU business leaders to develop recommendations on trade policy, issued invitations Sept. 7 to Ivax CEO Philip Frost, MD, Schein CEO Martin Sperber, Sicor CEO Carlo Salvi, Barr CEO Bruce Downey, and Mylan CEO Milan Puskar to attend the conference. The generic industry had been excluded from previous discussions on generic pharmaceutical trade issues, resulting in FDA's withdrawal from involvement in TABD meetings